Intelligent Bio Solutions Inc. Reports First Quarter Ending September 30, 2022, Preliminary Financial Results and Recent Business Highlights

Intelligent Bio Solutions Inc. Reports First Quarter Ending September 30, 2022, Preliminary Financial Results and Recent Business Highlights Acquired Intelligent Fingerprinting Limited and its proprietary drugs of abuse screening technology. Announced new additions to Board of Directors and name change to Intelligent Bio Solutions Inc.  Company to host conference call & webcast today at 4:30 […]

Intelligent Bio Solutions Inc. Announces Airline Adopts Fingerprint Drug Screening System for In-house Testing

Intelligent Bio Solutions Inc. Announces Airline Adopts Fingerprint Drug Screening System for In-house Testing   Eastern Airways to use portable, hygienic, non-invasive fingerprint sweat test to support new European Aviation Authority regulations   NEW YORK, Nov. 03, 2022 (GLOBE NEWSWIRE) — Intelligent Bio Solutions Inc. (Nasdaq: INBS) (the “Company”), a life sciences company developing non-invasive, […]

Intelligent Bio Solutions Inc. Announces Leading U.K. Container Haulier Switching to Fingerprint Drug Screening System for In-house Testing

Intelligent Bio Solutions Inc. Announces Leading U.K. Container Haulier Switching to Fingerprint Drug Screening System for In-house Testing   Goldstar Transport to Remove Urine Testing for Sweat Based Technology   New York, NY, October 31, 2022 – Intelligent Bio Solutions Inc. (Nasdaq: INBS) (the “Company”), a life sciences company delivering intelligent, non-invasive, real-time testing solutions, […]

GBS Inc. Acquires Intelligent Fingerprinting Limited and its Proprietary Drugs of Abuse Screening Technology

GBS Inc. Initiates Company Name Change to Intelligent Bio Solutions Inc. (INBS) and Announces Key Executive Appointments   Name change to more closely reflect firm’s expanding portfolio of intelligent, efficient, convenient and practical non-invasive and drug testing technologies and products – Harry Simeonidis appointed as Chief Executive Officer – David Jenkins and Jason Isenberg appointed […]

GBS Inc. Acquires Intelligent Fingerprinting Limited and its Proprietary Drugs of Abuse Screening Technology

GBS Inc. Acquires Intelligent Fingerprinting Limited and its Proprietary Drugs of Abuse Screening Technology The transaction further solidifies GBS’ leadership in non-invasive, real-time diagnostic testing with an expanded portfolio and geographical reach GBS’ global footprint includes operations in Australia, United Kingdom and the US New York, NY, October 4, 2022 (GLOBE NEWSWIRE) — GBS Inc. (Nasdaq: GBS), […]

GBS Inc. to Initiate Manufacturing on the University of Newcastle Australia Campus

GBS Inc. to Initiate Manufacturing on the University of Newcastle Australia Campus New York, NY, June 23, 2022 (GLOBE NEWSWIRE) – GBS Inc. (Nasdaq: GBS), a life sciences company developing non-invasive, real-time diagnostic testing for patients and their primary health practitioners at point-of-care, today announced that the Company and the University of Newcastle in Australia […]